Intelligence Platform
Patents
Browse 14,889 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6555127
Multi-spike release formulation for oral drug delivery
expired patentUS 6555116
Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin
expired patentUS 6552058
Oxazolidinedione derivatives and their use
expired patentUS 6551989
Preventing airway mucus production by administration of EGF-R antagonists
expired patentUS 6552006
Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen
expired patentUS 6552053
Controlling attention and memory by altering neuronal carbonic anhydrase activity
expired patentUS 6552054
Chromone derivatives, process for the preparation of the same and uses thereof
expired patentUS 6551830
Rh blood group antigen compositions and methods of use
expired patentUS 6551774
Diagnostic methods for conditions associated with elevated cellular levels of telomerase a
expired patentUS 6551588
Tumor radiosensitization using gene therapy
expired patentUS 6551559
Sol-gel coated polarization vessels
expired patentUS 6548081
Bioabsorbable composites of derivatized hyaluronic acid and other biodegradable, biocompat
expired patentUS 6548068
Enhanced immune response to an antigen by a composition of a recombinant virus expressing
expired patentUS 6545149
Synthesis and crystallization of piperazine ring-containing compounds
expired patentUS 6545142
Single domain ligands, receptors comprising said ligands, methods for their production, an
expired patentUS 6545009
Retinoid-related receptor function regulating agent
expired patentUS 6544999
Polymorphs of N-methyl-N-(3-{3-[2- thienylcarbonyl]-pyrazol-[1,5-&agr;]- pyrimidin-9-yl}ph
expired patentUS 6544549
Multilamellar coalescence vesicles (MLCV) containing biologically active compounds
expired patentUS 6544750
Peptide analogs as selective inhibitors of thrombin activation of protease activated recep
expired patentUS 6541001
Vaccine composition and method of using the same
expired patentUS 6541469
CRF receptor antagonists and methods relating thereto
expired patentUS 6541230
Detoxification with sponges or foams containing plurality of enzymes and encapsulated indi
expired patentUS 6541199
Identification of a new ehrlichia species from a patient suffering from ehrlichiosis
expired patentUS 6541195
Correction of genetic defects using chemical chaperones
expired